Efficacy and safety of fractional carbon dioxide laser for treatment of unwanted facial freckles in phototypes II-IV: a pilot study
- PMID: 24917080
- DOI: 10.1007/s10103-014-1610-8
Efficacy and safety of fractional carbon dioxide laser for treatment of unwanted facial freckles in phototypes II-IV: a pilot study
Erratum in
- Lasers Med Sci. 2014 Nov;29(6):1943. Hay, Rania Abdel [Corrected to Abdel Hay, Rania]
Abstract
Facial freckles are a cosmetic concern to Egyptians, particularly young females. Several therapeutic lines exist with variable response rates and limitations. Fractional carbon dioxide (FCO2) laser provides minimal ablation and therefore less down time and less side effects. The efficacy and safety of this laser technology have still not been studied in freckles. The aim of this study is to assess the efficacy and safety of FCO2 laser in the treatment of unwanted facial freckles in Egyptians. Twenty patients undergone a single session of FCO2 laser and then were followed up clinically a month later. Photographs were taken before treatment and at follow-up visit and were assessed by three blinded investigators. Percent of global improvement was measured on a 4-point grading scale. Patient's satisfaction and adverse events were recorded. Two patients (10 %) showed grade 1 improvement, while eight patients (40 %) showed grade 2 improvement. Nine patients (45 %) showed grade 3 improvement, and only one patient (5 %) showed grade 4 improvement. FCO2 laser resurfacing is effective and safe in treatment of facial freckles in skin phototypes II-IV. It can offer a more practical alternative to topical treatments, and a cheaper alternative to Q-switched lasers.
Similar articles
-
Fractional Carbon Dioxide Laser in Patients with Skin Phototypes III to VI and Facial Burn Sequelae: 1-Year Follow-Up.Plast Reconstr Surg. 2018 Sep;142(3):342e-350e. doi: 10.1097/PRS.0000000000004688. Plast Reconstr Surg. 2018. PMID: 30148783
-
Efficacy of autologous platelet-rich plasma combined with fractional ablative carbon dioxide resurfacing laser in treatment of facial atrophic acne scars: A split-face randomized clinical trial.Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):162-8. doi: 10.4103/0378-6323.174378. Indian J Dermatol Venereol Leprol. 2016. PMID: 26924405 Clinical Trial.
-
Efficacy and safety of fractional CO2 laser versus fractional Er:YAG laser in the treatment of facial skin wrinkles.Lasers Med Sci. 2017 Feb;32(2):283-289. doi: 10.1007/s10103-016-2111-8. Epub 2016 Nov 24. Lasers Med Sci. 2017. PMID: 27885522 Clinical Trial.
-
Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.Lasers Surg Med. 2017 Jan;49(1):20-26. doi: 10.1002/lsm.22518. Epub 2016 Apr 13. Lasers Surg Med. 2017. PMID: 28134994 Review.
-
Efficacy and safety of erbium-doped yttrium aluminium garnet fractional resurfacing laser for treatment of facial acne scars.Indian J Dermatol Venereol Leprol. 2013 Mar-Apr;79(2):193-8. doi: 10.4103/0378-6323.107635. Indian J Dermatol Venereol Leprol. 2013. PMID: 23442457 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources